HeartWare International Inc. (NASDAQ:HTWR) shares saw an uptick in trading volume on Tuesday . 1,451,360 shares changed hands during mid-day trading, an increase of 26% from the previous session’s volume of 1,150,777 shares.The stock last traded at $57.46 and had previously closed at $57.55.

Several research firms have issued reports on HTWR. BTIG Research downgraded HeartWare International from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 29th. Wells Fargo & Co. downgraded HeartWare International from an “outperform” rating to a “market perform” rating in a research report on Wednesday, June 29th. Barclays PLC downgraded HeartWare International from an “overweight” rating to an “equal weight” rating and lifted their target price for the company from $35.00 to $58.00 in a research report on Wednesday, June 29th. SunTrust Banks Inc. downgraded HeartWare International from a “buy” rating to a “neutral” rating and lowered their target price for the company from $60.00 to $58.00 in a research report on Tuesday, June 28th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $66.00 target price (up previously from $45.00) on shares of HeartWare International in a research report on Monday, June 27th. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $51.92.

The stock’s 50 day moving average is $36.10 and its 200 day moving average is $34.72. The company’s market capitalization is $1.01 billion.

HeartWare International (NASDAQ:HTWR) last announced its quarterly earnings results on Wednesday, May 4th. The company reported ($0.95) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.79) by $0.16. The company had revenue of $55.10 million for the quarter, compared to analyst estimates of $60.07 million. The company’s revenue was down 21.3% on a year-over-year basis. On average, equities analysts predict that HeartWare International Inc. will post ($3.43) EPS for the current year.

In related news, SVP James Schuermann sold 1,000 shares of the firm’s stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $57.77, for a total value of $57,770.00. Following the transaction, the senior vice president now owns 12,043 shares of the company’s stock, valued at approximately $695,724.11. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

A hedge fund recently raised its stake in HeartWare International stock. Nationwide Fund Advisors increased its stake in HeartWare International Inc. (NASDAQ:HTWR) by 42.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 21,594 shares of the company’s stock after buying an additional 6,458 shares during the period. Nationwide Fund Advisors owned 0.12% of HeartWare International worth $1,088,000 as of its most recent filing with the SEC.

Heartware International, Inc is a medical device company. The Company develops and manufactures miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The Company operates in the segment of design and manufacture of medical devices.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.